Investment
Features
FeesSafety
Academy
More
Pluang+

Compare Diagnos Laboratorium Utama Tbk. (DGNS) vs Merck Tbk. (MERK) Price & Performance

Diagnos Laboratorium Utama Tbk.Trade
Merck Tbk.Trade

Price performance (Past 24H)

Key statistics

Diagnos Laboratorium Utama Tbk. vs Merck Tbk. — how do they compare? Diagnos Laboratorium Utama Tbk. trades at Rp224 (market cap 308B, 42.6K 24h volume), while Merck Tbk. trades at Rp3,850 (market cap 1.7T, 27.2K 24h volume). The key difference: Merck Tbk. is far larger — about 5.5× Diagnos Laboratorium Utama Tbk.'s market cap, and Diagnos Laboratorium Utama Tbk. is more actively traded (42.6K versus 27.2K). Which is the better fit depends on your goals.

DGNSMERK
Market Cap
308B1.7T
Volume
42.6K27.2K
Lot
426272
Turnover
9.61M104.39M
Average Price
225.663,837.87
Value
9.61M104.39M
Indicative Equilibrium Price
2303,850
Indicative Equilibrium Volume
1101

Returns comparison

Trailing returns across standard periods

Top news

Latest headlines on both assets

DGNS
View details
MERK
View details

About Diagnos Laboratorium Utama Tbk.

PT Diagnos Laboratorium Utama Tbk (the “Company”) was established in the Republic of Indonesia on August 29, 2007 under framework of the Domestic Capital Investment Law No. 6 Year 1968 based on Deed No.17 dated August 29, 2007, of Martinef, S.H., M.Si., Notary in Bekasi. The Company started its commercial operation in 2008.

Read more on DGNS

About Merck Tbk.

PT Merck Tbk (the Company) is domiciled in Indonesia and located at Jl. TB Simatupang No. 8, Pasar Rebo, East Jakarta, was established in framework of Law No. 1 of 1967 and Law No. 11 of 1970 on foreign capital investment by deed of notary public Eliza Pondaag, SH dated 14 October 1970 No. 29. PT Merck Indonesia is a member of the Merck International Group. The company produces pharmaceutical products with production facility in East Jakarta. It commenced its operation in 1974 in manufacturing medical products, such as Songobian and Neurobion.

Read more on MERK